SCHEMBL1492843

SCHEMBL1492843

COc1cccc(NC(=O)Nc2ccc(-c3ccnc(C)c3)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.64
RAB9A P51151 5/20 0.64
TP53 P04637 1/20 0.64
TSHR P16473 1/20 0.64
ALDH1A1 P00352 1/20 0.63
PSEN1 P49768 2/20 0.61
PSEN2 P49810 2/20 0.61
APH1B Q8WW43 2/20 0.61
NCSTN Q92542 2/20 0.61
APH1A Q96BI3 2/20 0.61
PSENEN Q9NZ42 2/20 0.61
RAF1 P04049 1/20 0.60
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
CNR1 P21554 1/20 0.58
MAPT P10636 5/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
LMNA P02545 2/20 0.58
HTT P42858 2/20 0.58
GAA P10253 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492858 0.95 CNR1 (0.65) NPC1RAB9ATP53TSHRALDH1A1
SCHEMBL1492839 0.88 PORCN (0.61) NPC1RAB9APSEN1PSEN2APH1B
SCHEMBL1492766 0.88 PSEN1 (0.56) NPC1RAB9ATP53PSEN1PSEN2
SCHEMBL1492696 0.88 CNR1 (0.60) NPC1RAB9APSEN1PSEN2APH1B
SCHEMBL1492873 0.86 PSEN1 (0.54) NPC1RAB9ATSHRALDH1A1PSEN1
SCHEMBL1492838 0.85 PORCN (0.55) NPC1RAB9ATP53TSHRPSEN1
SCHEMBL1492870 0.85 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1493028 0.85 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1493023 0.84 CNR1 (0.65) NPC1RAB9ATP53PSEN1PSEN2
SCHEMBL1492860 0.84 CNR1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 NPC1 569/4885RAB9A 1725/4885TP53 2235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.